Real-world experience of bimekizumab for adult patients with plaque psoriasis: A 52-week multicenter retrospective study

Affiliations

• ¹ Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
• ² Dermatology Research Institute, Calgary, Alberta, Canada.
• ³ Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
• ⁴ Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
• ⁵ Skin Health & Wellness Centre, Calgary, Alberta, Canada.
• ⁶ Dermatology Research Institute, Calgary, Alberta, Canada; Skin Health & Wellness Centre, Calgary, Alberta, Canada; Probity Medical Research, Waterloo, Ontario, Canada.
• ⁷ Division of Dermatology, McMaster University, Hamilton, Ontario, Canada; Dermatrials Research Inc. & Venderm Consulting, Hamilton, Ontario, Canada.
• ⁸ Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Probity Medical Research, Waterloo, Ontario, Canada; Division of Dermatology, Department of Medicine, Women's College Hospital, Toronto, Ontario, Canada; Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
• ⁹ Dermatology Research Institute, Calgary, Alberta, Canada; Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada; Skin Health & Wellness Centre, Calgary, Alberta, Canada; Probity Medical Research, Waterloo, Ontario, Canada; Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada; Section of Community Pediatrics, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada; Section of Pediatric Rheumatology, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada. Electronic address: vimal@dermatologyresearch.ca.